|
Mikhail Ivanovich Davydov ((ロシア語:Михаил Иванович Давыдов); born October 11, 1947) is a Russian doctor and medical scientist. He has received the Russian State Prize Laureate, is an Honored Science Worker of the Russian Federation, Director of the Russian Cancer Research Center, member of the Presidium and Academician of RAS, member and President of the Russian Academy of Medical Sciences. ==Biography== Davydov was born in Konotop, Sumy region, Ukraine. There was some element of chance that Mikhail Davydov became a surgeon. He graduated from the Suvorov Military School, and then served three years in the Airborne Troops. As for his mother she wanted her son to become a musician. But Michael decided that he would feel cramped in the art with his character. That time he came across Yuri German trilogy “My dear man” and decided to choose surgery. Thus Mikhail Davydov came to Moscow. In 1975, Mikhail Davydov graduated from the 1st Moscow Medical Institute named after Sechenov (being a student he worked as a laboratory assistant at the sub-department of operative surgery). Then there were residency training (1975–1977) and postgraduate studies (1977–1980) in the RAMS USSR Cancer Research Center named after N.N. Blokhin. He defended his master’s and doctoral dissertations then became a professor. In 1986, Mikhail Ivanovich became a leading researcher in the Thoracic department. From 1988 to the present day he is the head of the Department of abdominothoracic oncology. From 1992 till present he is the Director of the N. N. Blokhin Russian Cancer Research Center of RAMS. He is the Chief Oncologist of the Medical Center of the RF Presidential Department for Property Management. He also heads the sub-department of oncology in the Russian State Medical University. M.I. Davydov is known in Russia and abroad as a scientist who dedicated his scientific and practical activities to developing new and improving existing methods of the surgical treatment of lung, esophageal, stomach cancer, mediastinal mass. He developed a principally new technique of intrapleural gastro-esophageal and esophageal-intestinal anastomoses which is notable for its original technical performance, absolute security and highly adjusted to physiology; the surgical measures have been developed where the results of treatment of lung, esophageal, stomach cancer are improved due to the mediastinal and retroperitoneal lymph node dissection. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Mikhail Davydov (oncologist)」の詳細全文を読む スポンサード リンク
|